全基因組定序市場規模、佔有率和成長分析：按技術、產品/服務、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球全基因組定序市場價值為 34 億美元，預計到 2025 年將成長至 40.3 億美元，到 2033 年將成長至 157.8 億美元，在預測期（2026-2033 年）內複合年成長率為 18.6%。

全球全基因組定序市場正經歷顯著成長，這主要得益於成本的大幅降低和高通量定序技術的進步。這使得定序技術從僅用於研究的工具轉變為標準的臨床工具。該技術能夠進行全面的DNA定序，從而促進精準醫療、感染疾病追蹤和大規模流行病學研究。從高成本且耗時的調查方法到快速且經濟的解決方案的轉變，正在推動其在腫瘤學、罕見疾病和公共衛生等領域的臨床應用拓展。此外，人工智慧的融入進一步改變了市場格局，提高了數據準確性，加快了分析速度，並有助於臨床醫生做出可操作的解讀，從而促進了測序技術的更廣泛應用，並為與製藥公司和創新診斷市場的合作創造了機會。

全球全基因組定序市場的成長要素

全球全基因測序市場的主要促進因素之一是遺傳性疾病和慢性病盛行率的不斷上升，這需要先進的診斷工具和個人化醫療方法。人們對精準醫療日益成長的興趣，以及定序技術的進步帶來的成本降低和準確性提升，正在推動全基因測序的需求。此外，政府和私人機構對基因組研究和旨在闡明健康和疾病背後遺傳因素的計劃投入的增加，也進一步促進了市場成長。這些因素，加上全基因組定序在腫瘤學、生殖醫學和罕見疾病等領域的日益廣泛的應用，共同建構了一個蓬勃發展的市場格局。

全球全基因組定序市場面臨的限制因素

全球全基因組定序市場的主要限制因素之一是定序技術及相關分析軟體的高成本。儘管定序調查方法不斷進步，但購買先進設備所需的初始投資以及耗材和維護的持續成本，對小規模實驗室和機構而言仍構成障礙。此外，這些成本也可能成為發展中地區醫療服務提供者獲取全基因組定序的障礙，阻礙其廣泛應用。另外，教育和研究機構的預算限制也會限制投資，抑制創新，並縮小針對不同族群進行全面基因組研究的潛力。

全球全基因測序市場趨勢

隨著臨床應用範圍的擴大，全球全基因測序市場正經歷顯著的變革，該技術擴大應用於常規腫瘤分析、藥物基因體學和感染疾病監測等領域。這一趨勢的驅動力在於臨床醫生對全基因組測序的接受度不斷提高以及跨學科合作的日益加強，促使保險公司和醫療保健系統認知到，透過提高診斷準確性和實現個性化治療方案，全基因組測序能夠帶來長期的臨床價值。將全基因組定序整合到臨床工作流程中，並建立​​多學科腫瘤學會議，有助於提升報告的可操作性和決策支援能力。反過來，這又促進了相關項目和研究的開展，從而推動指南的納入和在各種臨床環境中的更廣泛應用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球全基因組定序市場規模：依技術分類

• 合成定定序（SBS）
• 離子半導體定序
• 單分子即時（SMRT）定序
• 奈米孔定序
• 其他

全球全基因組定序市場規模：依產品/服務分類

• 裝置
• 消耗品
• 軟體與生物資訊學
• 定序服務

全球全基因組定序市場規模：按應用領域分類

• 臨床診斷
• 腫瘤學
• 罕見疾病的診斷
• 生殖和產前檢查
• 感染疾病監測
• 藥物基因體學
• 農業和畜牧業調查
• 群體基因組學
• 藥物發現與開發
• 學術和轉化研究
• 其他

全球全基因組定序市場規模：依最終用戶分類

• 學術研究機構
• 醫院/診斷檢查室
• 製藥和生物技術公司
• 受託研究機構（CRO）
• 政府和公共衛生機構
• 其他

全球全基因組定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Illumina
• Thermo Fisher Scientific
• QIAGEN
• Pacific Biosciences
• Oxford Nanopore Technologies
• BGI Genomics
• F. Hoffmann-La Roche
• Agilent Technologies
• Danaher Corporation
• PerkinElmer
• Bio-Rad Laboratories
• 10x Genomics
• Eurofins Scientific
• Ginkgo Bioworks
• Novogene
• Azenta Life Sciences
• Macrogen
• SeqMatic
• Gene by Gene
• Complete Genomics

結論與建議

Global Whole Genome Sequencing Market size was valued at USD 3.4 Billion in 2024 and is poised to grow from USD 4.03 Billion in 2025 to USD 15.78 Billion by 2033, growing at a CAGR of 18.6% during the forecast period (2026-2033).

The global whole genome sequencing market is experiencing significant growth, primarily driven by the substantial reduction in costs and advancements in high-throughput sequencing technologies, which have transitioned sequencing from an exclusive research tool to a staple of clinical practice. This technology allows for comprehensive DNA sequencing, enhancing precision medicine, infection tracking, and large-scale epidemiological studies. The evolution from expensive, time-consuming methodologies to rapid, affordable solutions has catalyzed increased clinical applications in oncology, rare diseases, and public health. Moreover, the integration of AI is further transforming the landscape by enhancing data accuracy, expediting analysis, and facilitating actionable interpretations for clinicians, thereby fostering wider implementation and creating opportunities for pharmaceutical collaborations and innovative diagnostic markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Genome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Genome Sequencing Market Segments Analysis

Global whole genome sequencing market is segmented by technology, product & service, application, end user and region. Based on technology, the market is segmented into Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing and Others. Based on product & service, the market is segmented into Instruments, Consumables, Software & Bioinformatics and Sequencing Services. Based on application, the market is segmented into Clinical Diagnostics, Oncology, Rare Disease Diagnosis, Reproductive & Prenatal Testing, Infectious Disease Surveillance, Pharmacogenomics, Agriculture & Animal Research, Population Genomics, Drug Discovery & Development, Academic & Translational Research and Others. Based on end user, the market is segmented into Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Government & Public Health Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Genome Sequencing Market

One of the primary market drivers for the Global Whole Genome Sequencing Market is the increasing prevalence of genetic disorders and chronic diseases, which necessitates advanced diagnostic tools and personalized medicine approaches. The growing focus on precision medicine, alongside advancements in sequencing technologies that reduce costs and improve accuracy, is propelling demand for whole genome sequencing. Additionally, the rise in government and private funding for genomics research and initiatives aimed at understanding genetic contributions to health and disease further stimulate market growth. These factors, combined with the expanding applications in areas such as oncology, reproductive health, and rare diseases, are fostering a robust market landscape.

Restraints in the Global Whole Genome Sequencing Market

One key market restraint for the Global Whole Genome Sequencing Market is the high cost associated with sequencing technologies and the associated analysis software. Despite advancements in sequencing methodologies, the initial investment required for sophisticated equipment and ongoing expenses for consumables and maintenance can be prohibitive for smaller laboratories and institutions. Additionally, these costs can lead to limited accessibility for healthcare providers in developing regions, hindering the widespread adoption of whole genome sequencing. Furthermore, budget constraints within educational and research institutions can restrict investments, stalling innovation and limiting the potential for comprehensive genomic research across diverse populations.

Market Trends of the Global Whole Genome Sequencing Market

The Global Whole Genome Sequencing market is witnessing a significant shift as clinical applications expand, with the technology increasingly utilized for routine oncology profiling, pharmacogenomics, and infectious disease surveillance. This trend is fueled by heightened clinician adoption and enhanced interdisciplinary collaboration, prompting payers and health systems to acknowledge the long-term clinical value offered through improved diagnostic yield and personalized treatment approaches. The integration of whole genome sequencing into clinical workflows, along with the establishment of multidisciplinary tumor boards, enhances actionable reporting and decision-making support, thereby fostering the development of programs and research that promote guideline incorporation and broader acceptance in various clinical care settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Whole Genome Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing by Synthesis (SBS)
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing
• Nanopore Sequencing
• Others

Global Whole Genome Sequencing Market Size by Product & Service & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• Software & Bioinformatics
• Sequencing Services

Global Whole Genome Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Oncology
• Rare Disease Diagnosis
• Reproductive & Prenatal Testing
• Infectious Disease Surveillance
• Pharmacogenomics
• Agriculture & Animal Research
• Population Genomics
• Drug Discovery & Development
• Academic & Translational Research
• Others

Global Whole Genome Sequencing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Government & Public Health Organizations
• Others

Global Whole Genome Sequencing Market Size & CAGR (2026-2033)

• North America (Technology, Product & Service, Application, End User)
  • US
  • Canada
• Europe (Technology, Product & Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeqMatic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene by Gene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Complete Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations